New Key Statistics Module, Z-Score and F-Score
OTCPK:SNPHF Key Ratios
Market Cap $ M | 3,996.02 |
Enterprise Value $ M | 3,376.22 |
P/E(ttm) | 23.79 |
PE Ratio without NRI | 23.79 |
Forward PE Ratio | 17.51 |
Price/Book | 2.08 |
Price/Sales | 2.09 |
Price/Free Cash Flow | 9.92 |
Price/Owner Earnings | 12.27 |
Payout Ratio % | 0.47 |
Revenue (TTM) $ M | 2,037.00 |
EPS (TTM) $ | 0.49 |
Beneish M-Score | -3.23 |
10-y EBITDA Growth Rate % | -3.50 |
5-y EBITDA Growth Rate % | -9.60 |
y-y EBITDA Growth Rate % | 219.10 |
EV-to-EBIT | 15.64 |
EV-to-EBITDA | 10.07 |
PEG | -- |
Shares Outstanding M | 348.72 |
Net Margin (%) | 8.64 |
Operating Margin % | 12.33 |
Pre-tax Margin (%) | 9.80 |
Quick Ratio | 2.08 |
Current Ratio | 2.54 |
ROA % (ttm) | 6.12 |
ROE % (ttm) | 8.62 |
ROIC % (ttm) | 10.74 |
Dividend Yield % | 1.82 |
Altman Z-Score | 4.94 |
SNPHF Number of Guru Trades
SNPHF Volume of Guru Trades
Gurus Latest Trades with OTCPK:SNPHF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
OTCPK:SNPHF is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Santen Pharmaceutical Co Ltd Insider Transactions
No Available Data
News about OTCPK:SNPHF
Total 0- 1